Treatment of Meniere's disease with simultaneous triple semicircular canal occlusion and cochlear implantation.
Cochlear implantation
Meniere’s disease
Sensorineural hearing loss
Triple semicircular canal occlusion
Vertigo
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
27 Dec 2023
27 Dec 2023
Historique:
received:
08
07
2023
accepted:
30
11
2023
medline:
27
12
2023
pubmed:
27
12
2023
entrez:
27
12
2023
Statut:
aheadofprint
Résumé
Report three cases of simultaneous triple semicircular canal occlusion (TSCO) and cochlear implantation (CI) as the treatment of intractable Meniere's disease (MD). Patients with MD can present occasionally with intractable vertigo and profound sensorineural hearing loss (SNHL). TSCO and CI have been proposed to control vertigo and restore profound deafness in patients with MD separately. However, a few studies have reported simultaneous TSCO and CI in the same surgical procedure for the treatment of MD. In the present study, we described three patients with MD showing incapacitating vertigo and severe SNHL who underwent simultaneous TSCO and CI after examinations of auditory system, vestibular system, and imaging. Their symptoms were significantly alleviated during the follow-up period. The combined TSCO and CI remains a viable treatment option which is effective for the control of vertigo as well as the restoring of hearing in patients with MD.
Identifiants
pubmed: 38150022
doi: 10.1007/s00405-023-08387-x
pii: 10.1007/s00405-023-08387-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Natural Science Foundation of China
ID : 82171137
Organisme : National Natural Science Foundation of China
ID : 81970891
Organisme : National Natural Science Foundation of China
ID : 81970876
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Lopez-Escamez JA, Carey J, Chung WH et al (2015) Diagnostic criteria for Meniere’s disease. J Vestib Res 25(1):1–7
doi: 10.3233/VES-150549
pubmed: 25882471
Lopez-Escamez JA, Vela J, Frejo L (2023) Immune-related disorders associated with Meniere’s disease: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. https://doi.org/10.1002/ohn.386
doi: 10.1002/ohn.386
pubmed: 37272729
Parra-Perez AM, Lopez-Escamez JA (2023) Types of inheritance and genes associated with familial Meniere disease. J Assoc Res Otolaryngol. https://doi.org/10.1007/s10162-023-00896-0
doi: 10.1007/s10162-023-00896-0
pubmed: 37022572
pmcid: 10335989
Schuknecht HF (1984) The pathophysiology of Meniere’s disease. Am J Otol 5(6):526–527
pubmed: 6393773
Basura GJ, Adams ME, Monfared A et al (2020) Clinical practice guideline: Meniere’s disease. Otolaryngol Head Neck Surg 162(2_suppl):S1–S55
pubmed: 32267799
Espinosa-Sanchez JM, Lopez-Escamez JA (2020) The pharmacological management of vertigo in Meniere disease. Expert Opin Pharmacother 21(14):1753–1763
doi: 10.1080/14656566.2020.1775812
pubmed: 32539493
Wright T (2015) Meniere’s disease. BMJ Clin Evid 2015:0505
pubmed: 26545070
pmcid: 4636025
Nevoux J, Franco-Vidal V, Bouccara D et al (2017) Diagnostic and therapeutic strategy in Meniere’s disease. Guidelines of the French otorhinolaryngology-head and neck surgery society (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis 134(6):441–444
doi: 10.1016/j.anorl.2016.12.003
pubmed: 28065602
Fife TA, Lewis MP, May JS et al (2014) Cochlear implantation in Meniere’s disease. JAMA Otolaryngol Head Neck Surg 140(6):535–539
doi: 10.1001/jamaoto.2014.550
pubmed: 24789018
Mick P, Amoodi H, Arnoldner C et al (2014) Cochlear implantation in patients with advanced Meniere’s disease. Otol Neurotol 35(7):1172–1178
doi: 10.1097/MAO.0000000000000202
pubmed: 24366468
Lustig LR, Yeagle J, Niparko JK et al (2003) Cochlear implantation in patients with bilateral Meniere’s syndrome. Otol Neurotol 24(3):397–403
doi: 10.1097/00129492-200305000-00009
pubmed: 12806291
Yin S, Chen Z, Yu D et al (2008) Triple semicircular canal occlusion for the treatment of Meniere’s disease. Acta Otolaryngol 128(7):739–743
doi: 10.1080/00016480701730000
pubmed: 18568514
Loureiro RM, Sumi DV, Lemos MD et al (2019) (2019) The role of magnetic resonance imaging in Meniere disease: the current state of endolymphatic hydrops evaluation. Einstein (Sao Paulo) 17(1):eMD4743
doi: 10.31744/einstein_journal/2019MD4743
pubmed: 30810586
Perez-Carpena P, Lopez-Escamez JA (2020) Current understanding and clinical management of Meniere’s disease: a systematic review. Semin Neurol 40(1):138–150
doi: 10.1055/s-0039-3402065
pubmed: 31887752
Küppers P, Ahrens H, Blessing R (1994) Continuous intratympanic gentamycin infusion in Meniere disease. HNO 42(7):429–433
pubmed: 7928434
Doobe G, Ernst A, Ramalingam R et al (2015) Simultaneous labyrinthectomy and cochlear implantation for patients with single-sided Meniere’s disease and profound sensorineural hearing loss. Biomed Res Int 2015:457318
doi: 10.1155/2015/457318
pubmed: 26380275
pmcid: 4561297
Silverstein H, Jackson LE (2002) Vestibular nerve section. Otolaryngol Clin North Am 35(3):655–673
doi: 10.1016/S0030-6665(02)00024-5
pubmed: 12486846
Zhang Y, Cheng Y, Chen Z et al (2021) Case report: preservation of otolithic function after triple semicircular canal occlusion in a patient with intractable Meniere disease. Front Neurol 12:713275
doi: 10.3389/fneur.2021.713275
pubmed: 35002908
pmcid: 8732767
Jiang Y, Xu M, Yao Q et al (2022) Changes of vestibular symptoms in Meniere’s disease after triple semicircular canal occlusion: a long-term follow-up study. Front Neurol 13:797699
doi: 10.3389/fneur.2022.797699
pubmed: 35185763
pmcid: 8854354
Vallés-Varela H, Royo-López J, Carmen-Sampériz L et al (2013) The cochlear implant as a tinnitus treatment. Acta Otorrinolaringol Esp 64(4):253–257
doi: 10.1016/j.otorri.2012.11.008
pubmed: 23507664